Reports for TENOFOVIR DISOPROXIL FUMARATE
Ingredient
TENOFOVIR DISOPROXIL FUMARATE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Avoided shortage | 2017-09-22 | 2018-12-19 | 23172 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2017-09-27 | 2017-10-02 | 23663 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Resolved | 2018-01-02 | 2018-08-29 | 34559 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2018-03-05 | 2018-03-20 | 41868 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 300MG 200MG | TABLET | Resolved | 2018-04-27 | 2019-06-19 | 47356 |
| APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-01-02 | 2019-03-29 | 70748 |
| MYLAN-TENOFOVIR DISOPROXIL | 300MG | TABLET | Avoided shortage | 2019-02-21 | 2019-03-05 | 76496 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-04-03 | 2019-04-23 | 80423 |
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-04-04 | 2019-05-21 | 80530 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
Showing 1 to 1 of 1